Bevacizumab
Latest
1 in 12 monthsCurrent Oncology Reports
Pharmacological Treatment for Adamantinomatous Craniopharyngioma
ReviewInterventions
Related
- Angiogenesis1
- BRAF1
- CTNNB11
- Cellular senescence1
- GLP-1 and incretin signalling1
- Hedgehog signalling1
- IL-61
- Inflammation1
- MC4R1
- Sex hormone signalling (oestrogen, androgen)1
- Wnt/β-catenin signalling1
- Adamantinomatous craniopharyngioma1
- Braf/mek inhibitors1
- Cardiovascular disease1
- Craniopharyngioma1
- Diabetes mellitus1